Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Taber and Nicole Pilch.
David Taber
Connection Strength
6.005
Nicole Pilch
  1. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy. 2021 01; 41(1):119-131.
    View in: PubMed
    Score: 0.795
  2. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371.
    View in: PubMed
    Score: 0.667
  3. Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. Am J Nephrol. 2018; 47(3):191-199.
    View in: PubMed
    Score: 0.655
  4. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.187
  5. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.182
  6. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149.
    View in: PubMed
    Score: 0.180
  7. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.177
  8. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94.
    View in: PubMed
    Score: 0.170
  9. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types. Transplantation. 2018 09; 102(9):1440-1452.
    View in: PubMed
    Score: 0.169
  10. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.155
  11. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169.
    View in: PubMed
    Score: 0.152
  12. Depression, Resource Utilization, and Outcomes Following Liver Transplant. Prog Transplant. 2016 Sep; 26(3):270-6.
    View in: PubMed
    Score: 0.145
  13. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.144
  14. Value of solid organ transplant-trained pharmacists in transplant infectious diseases. Curr Infect Dis Rep. 2015 Apr; 17(4):475.
    View in: PubMed
    Score: 0.133
  15. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015 Mar; 29(3):222-6.
    View in: PubMed
    Score: 0.132
  16. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.127
  17. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.125
  18. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
    View in: PubMed
    Score: 0.125
  19. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.122
  20. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.120
  21. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.115
  22. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.115
  23. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44.
    View in: PubMed
    Score: 0.114
  24. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.114
  25. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.113
  26. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12.
    View in: PubMed
    Score: 0.111
  27. Early Assessment of National Kidney Allocation Policy Change. J Am Coll Surg. 2022 04 01; 234(4):565-570.
    View in: PubMed
    Score: 0.054
  28. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.050
  29. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy. 2021 01; 41(1):6-13.
    View in: PubMed
    Score: 0.049
  30. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
    View in: PubMed
    Score: 0.049
  31. Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522.
    View in: PubMed
    Score: 0.044
  32. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
    View in: PubMed
    Score: 0.040
  33. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
    View in: PubMed
    Score: 0.036
  34. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
    View in: PubMed
    Score: 0.036
  35. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
    View in: PubMed
    Score: 0.035
  36. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
    View in: PubMed
    Score: 0.033
  37. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
    View in: PubMed
    Score: 0.032
  38. Building a business plan to support a transplantation pharmacy practice model. Am J Health Syst Pharm. 2014 May 01; 71(9):751-7.
    View in: PubMed
    Score: 0.031
  39. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
    View in: PubMed
    Score: 0.031
  40. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013 Sep-Oct; 27(5):732-41.
    View in: PubMed
    Score: 0.030
  41. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013 May; 33(5):483-8.
    View in: PubMed
    Score: 0.029
  42. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8.
    View in: PubMed
    Score: 0.029
  43. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7.
    View in: PubMed
    Score: 0.027
  44. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.